Prefilled Syringes Market Size By Type (Glass, Plastic), By Design (Single-chamber, Dual-chamber), By Applications (Diabetes, Rheumatoid Arthritis, Anaphylaxis, Antithrombotic/Thrombolytic Therapy), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2021 - 2027

Prefilled Syringes Market Size

Prefilled Syringes Market size surpassed USD 5.8 billion in 2020 and is expected to witness over 11.8% CAGR from 2021 to 2027.
 

Growing demand for advanced drug delivery devices for accurate dosing and improved safety will propel the market growth. Increasing prevalence of diabetes and rheumatoid arthritis, and escalating adoption of biosimilars in developed regions are some other factors that will fuel the market expansion. Additionally, the COVID-19 pandemic and similar other historical public health emergencies have shown importance of advanced drug delivery systems during tough times.
 

Prefilled Syringes Market Trends

Technological advancements integrated in prefilled syringes in North America and other developed regions will positively impact the market revenue during the forecast period. Advancements introduced in the prefilled syringes have enhanced ease of use, reduced wastage of drugs and have significantly improved dosing accuracy. Manufacturers are also introducing enhancements in the component materials. For instance, currently plastic prefilled syringes have been manufactured that offer high heat resistance. These syringes are less permeable to water and are extremely light weight as compared to the conventional glass syringes. Thus, such developments in the prefilled syringes have promoted operational ease that increases its acceptance during the forecast timeline. Recently developed prefilled syringes eliminate the risk of administering wrong dosage regardless of syringe orientation. Thus, advancements in technology have encouraged developments in the prefilled syringes that will prove beneficial for the industry growth.
 

Prefilled Syringes Market Analysis

The glass-based prefilled syringes market accounted for USD 4.1 billion in 2020. Currently, most prefilled syringes are made of glass. This is due to the fact that most of the glass prefilled syringes allow delivery of highly viscous medications. Furthermore, glass prefilled syringes can be utilized across a wide range of therapeutic areas, such as blood stimulants, vaccines, and therapeutic proteins while increasing product life span that will positively impact the segment growth.
 

The single-chamber design segment in the prefilled syringes market exceeded USD 4.6 billion in 2020 an account of advantages pertaining to single-chamber prefilled syringes over vials such as precise dosing and safety. Moreover, simple storage and ease of usage associated with single chamber design will increase its preference over the forecast period, thus also proving beneficial for the overall industry expansion.
 

The diabetes segment held 34% of the prefilled syringes market share in 2020. Diabetes requires constant medications for treatment. Rising prevalence of diabetes coupled with favourable demographic trends also increases demand for prefilled syringes with insulin that will prove beneficial for segment revenue.
 

North America prefilled syringes market is predicted to showcase around 12% growth rate till 2027 owing to the rising geriatric population base susceptible to chronic diseases in the U.S. and China. High acceptance of patient safety measures along with rapid adoption of prefilled syringes in this region will further enhance the market expansion. The market will also prosper due to the presence of major industry players with strong distribution network that are associated with prefilled syringes business.
 

Prefilled Syringes Market Share

Some of the prominent companies functioning in the prefilled syringes market include

• Gerresheimer
• Stevanato Group
• Baxter International
• Catalent
• Becton Dickinson (BD)
• Fresenius Kabi
• SCHOTT

These market participants are undertaking several organic and inorganic growth strategies to capture a higher revenue share in this industry.
 

Some of the recent industry developments:

• In December 2020, Becton, Dickinson and Company (BD) to invest around USD 1.2 billion to expand its manufacturing technology and capacity of prefilled syringes. This strategy enhanced the company to create strong position in the market.
   
• In March 2019, SCHOTT launched syriQ BioPure that is world’s first lubricant free prefilled glass syringe. This innovative launch enabled the company to extend its product portfolio in this industry.
   

The prefilled syringes market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:

Click here to Buy Section of this Report

 

Market, By Type, 2016-2027 (USD Million)

• Glass
• Plastic

Market, By Design, 2016-2027 (USD Million)

• Single-chambers
• Dual-chamber

Market, By Application, 2016-2027 (USD Million)

• Diabetes
• Rheumatoid arthritis
• Anaphylaxis
• Antithrombotic/thrombotic therapy
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia